NY S07637

Establishes the Prescription Monitoring Program Registry to collect, monitor, and report real-time data on prescribing and dispensing of Schedule II, III, and IV controlled substances, accessible to practitioners and pharmacists to review patient controlled substance histories before prescribing or dispensing.

Requires all prescriptions written in New York State to be issued electronically on serialized official prescription forms within two years of regulatory standards being established, with limited exceptions for veterinarians, technological failures, and practitioners receiving waivers due to hardship.

Updates controlled substance schedules by adding new drugs including tapentadol (Schedule II), fospropofol and carisoprodol (Schedule IV), tramadol (Schedule IV), and ezogabine and lacosamide (Schedule V), and reorganizes hydrocodone-containing products based on ingredient quantities.

Requires prescription forms and electronic prescriptions to include sections indicating whether patients are limited English proficient and their preferred language, and mandates the Department of Health establish minimum standards for storage, reporting, and record keeping of specified controlled substances.

Establishes a voluntary safe disposal program allowing members of the public to surrender unused controlled substances from Schedules II-V anonymously and securely at law enforcement agency disposal sites, to be publicized through the prescription pain medication awareness program.